The adequate corpus luteum: miR-96 promotes luteal cell survival and progesterone production by Mohammed, Bushra et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The adequate corpus luteum: miR-96 promotes luteal cell
survival and progesterone production
Citation for published version:
Mohammed, B, Sontakke, S, Ioannidis, J, Duncan, WC & Donadeu, F 2017, 'The adequate corpus luteum:
miR-96 promotes luteal cell survival and progesterone production' Journal of Clinical Endocrinology &
Metabolism, vol. 102, no. 7, pp. 2188-2198. DOI: 10.1210/jc.2017-00259
Digital Object Identifier (DOI):
10.1210/jc.2017-00259
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Journal of Clinical Endocrinology & Metabolism
Publisher Rights Statement:
This is the author's peer-reviewed manuscript as accepted for publication
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
 1 
 
The adequate corpus luteum: miR-96 promotes luteal cell survival and progesterone 1	
production   2	
Bushra T. Mohammed1*, Sadanand D. Sontakke1*, Jason Ioannidis1, W. Colin Duncan2, F. Xavier 3	
Donadeu1 4	
1The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, 5	
Easter Bush, Midlothian, EH25 9RG, UK 6	
2The Queen's Medical Research Institute, MRC Centre for Reproductive Health, 47 Little France 7	
Crescent, Edinburgh EH16 4TJ, UK 8	
*equal contribution 9	
Abbreviated Title: miR-96 regulates luteal development 10	
Key terms: miRNA, miR-96, ovary, progesterone, FOXO1, luteal cells, luteinized granulosa cells 11	
Word count: 3591 12	
Number of figures and tables: 6 13	
 14	
Corresponding author and person to whom print requests should be addressed: 15	
F. Xavier Donadeu  16	
The Roslin Institute and R(D)SVS, University of Edinburgh, Easter Bush, Midlothian, EH25 9RG, 17	
Scotland, UK, Tel. +44 (0)131-6519161 Fax. +44 (0)131 651 9105, xavier.donadeu@roslin.ed.ac.uk 18	
 19	
BTM, SDS and JI were supported by Kurdistan Regional Government-Iraq scholarship funds (College 20	
of Veterinary Medicine, University of Duhok), a Commonwealth PhD scholarship and a BBSRC case 21	
studentship, respectively. The Roslin Institute receives Strategic Grant funding from the BBSRC. 22	
Disclosure statement: The authors have nothing to disclose 23	
 2 
 
Abstract 24	
Context: Inadequate progesterone production from the corpus luteum is associated with pregnancy 25	
loss. Data available in model species suggest important roles of miRNAs in luteal development and 26	
maintenance.  27	
Objective: To comprehensively investigate the involvement of miRNAs during the ovarian follicle-28	
luteal transition  29	
Design: The effects of specific miRNAs on survival and steroid production by human luteinized 30	
granulosa cells (hLGCs) were tested using specific miRNA inhibitors. Candidate miRNAs were first 31	
identified through microarray analyses of follicular and luteal tissues in a bovine model.  32	
Setting: UK academic institution associated with teaching hospital 33	
Patients or other participants: hLGCs were obtained by standard transvaginal follicular fluid 34	
aspiration from 35 women undergoing assisted conception 35	
Intervention(s): Inhibition of candidate miRNAs in vitro  36	
Main outcome measure(s): Levels of miRNAs, mRNAs, FOXO1 protein, apoptosis and steroids 37	
were measured in tissues and/or cultured cells.  38	
Results: Two specific miRNA clusters, miR-183-96-182 and miR-212-132, were dramatically 39	
increased in luteal relative to follicular tissues. miR-96 and miR-132 were the most upregulated 40	
miRNAs within each cluster. Database analyses identified FOXO1 as a putative target of both these 41	
miRNAs.  In cultured hLGCs, inhibition of miR-96 increased apoptosis and FOXO1 protein levels, and 42	
decreased progesterone production. These effects were prevented by siRNA-mediated downregulation 43	
of FOXO1.  In bovine luteal cells, miR-96 inhibition also led to increases in apoptosis and FOXO1 44	
protein levels.  45	
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Conclusions: miR-96 targets FOXO1 to regulate luteal development through effects on cell survival 46	
and steroid production. The miR-183-96-182 cluster could provide a novel target for the manipulation 47	
of luteal function. 48	
 49	
Introduction   50	
In monovular species, such as humans, ovulation involves rupture of the wall of a mature follicle 51	
and release of the contained oocyte for fertilization. Following ovulation, the follicular remnants 52	
undergo profound remodeling resulting in formation of a highly vascular, highly steroidogenic corpus 53	
luteum (CL), with a critical role in establishment/maintenance of pregnancy. Luteal development 54	
involves fine-tuned changes in proliferation, survival, migration and differentiation simultaneously 55	
affecting a multitude of cell types (1).  Particularly critical is the differentiation of estrogen-producing 56	
follicular cells into luteal cells with the ability to produce high levels of progesterone. The importance 57	
of this is reflected in the association of luteal insufficiency and/or suboptimal progesterone levels with 58	
pregnancy failure in species including cattle, sheep and horses (2-4). Although a similar association has 59	
been proposed in humans (5), controversy exists on whether the CL is actually a primary cause of 60	
infertility in women (6).  A much-needed understanding of molecular regulation of luteal development 61	
in humans would provide clarification and assist in identifying novel therapeutic targets for fertility 62	
manipulation. 63	
miRNAs are ubiquitously involved in post-transcriptional gene regulation during tissue 64	
development/differentiation. Global miRNA profiles during follicular development have been reported 65	
in cattle, sheep and mice (7-9), and numerous miRNAs were shown to regulate follicular proliferation, 66	
survival and steroidogenesis (10-12).  In addition, a significant number of miRNAs change in 67	
expression during the follicle-luteal transition and luteal maturation (7,9,13,14), however, although 68	
specific roles have been demonstrated for some of these miRNAs in rodents, including in luteal 69	
angiogenesis (miR-17-5p and let-7b (15)), survival (miR-21 (16)), and LHCGR downregulation (miR-70	
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136-3p and miR-122 (17,18)), very limited information exists on their involvement in other species, 71	
particularly humans (14). 72	
A greater understanding of the roles of miRNAs in normal luteal development, and in particular the 73	
follicle-luteal transition, could provide important insight into human reproductive health. Considering 74	
this, we performed analysis both in cells from human patients and in tissues collected from cattle. Being 75	
a monovular species, cattle provide a convenient model to study human ovarian physiology, importantly 76	
allowing study of clinically-relevant follicular/luteal tissues difficult to access in women. Our studies 77	
identified a miRNA cluster which is highly expressed in the CL and plays a role in promoting luteal 78	
cell survival and steroidogenesis, providing a potential target for future interventions in human 79	
reproductive health. 80	
 81	
Methods 82	
Tissue collection 83	
Human luteinized granulosa cells (hLGCs) were obtained (19) from 35 donors undergoing assisted 84	
conception at the Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, UK. Ethical 85	
approval was given by the regional medical research ethics committee (2005/R/RM/11 and SR431), all 86	
women gave informed consent and cells were analyzed anonymously. Cells were centrifuged through 87	
Ficoll Paque Plus solution (1.077 g/cm3, GE Healthcare, UK), then the middle layer was collected and 88	
washed before culture. Cell viability was ~70%. 89	
Bovine tissues were collected at an abattoir. Ovarian pairs containing a visible CL were used to 90	
collect individual follicles >10 mm in diameter (8). Follicular walls and follicular fluid were snap-91	
frozen in LN2 and frozen at -80°C, respectively.  Corpora lutea corresponding to days 1-4 of an estrous 92	
cycle (20) were collected and snap-frozen. Bovine granulosa cells were obtained from follicles 4-8 mm 93	
in diameter (8,21). Luteal cells (steroidogenic and other cells including fibroblasts, endothelial and 94	
immune) were isolated using a modification of published protocols (22).  In brief, the CL was minced 95	
and digested twice in collagenase-II and BSA (both from Sigma-Aldrich, UK) at 37°C for 45 min. 96	
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Supernatants were filtered (100-µm) then incubated with DNase-I (Sigma-Aldrich) for 10 min at 37°C.  97	
After digestion, cells were filtered again (70-µm), washed and incubated with red cell blood lysis buffer 98	
(8.3 gm/l NH4Cl in 0.01 M Tris-HCl, pH= 7.5; Sigma-Aldrich) for 1 min. Cell viability was >80%.  99	
 100	
Cell culture 101	
Both hLGCs and bovine luteal cells were cultured in 24- or 12-well plates (Thermo-Fisher, UK; 102	
100,000 and 500,000 cells/well) in DMEM/F-12 (Life Technologies, UK) containing 2.5mM L-103	
Glutamine, 15mM HEPES, 1% Pen-Strep, Fetal bovine serum (FBS; 10% v/v for the first 24 h, 2% 104	
thereafter), ITS (Insulin (5 µg/ml), Transferrin (5 µg/ml) and sodium selenite (5 ng/ml)) and Fungizone 105	
(2.5 µg/ml; all from Sigma-Aldrich) in a humidified atmosphere at 37°C with 5% CO2.  Twenty-four 106	
hours later, cells were transfected with locked-nucleic acid (LNA) anti-miRNAs (Exiqon, Denmark; 50 107	
nM), two human FOXO1 siRNAs (ID#106654 and 106653; Life Technologies; 100 nM each) and/or a 108	
scrambled oligonucleotide (AllStars-Negative Control; Qiagen, UK; 50 or 100 nM) using Hiperfect 109	
reagent (Qiagen), and 1 or 2 days later they were collected for RNA, protein or Caspase 3/7 activity 110	
analyses while culture media were frozen. In some instances, after 6 days in culture hLGCs were treated 111	
with hCG (100 ng/ml; Serono Laboratories, UK) for 4 days after which RNA was collected. 112	
Progesterone and estradiol levels in culture media were quantified using Coat-A-Count 113	
radioimmunoassay (Siemens Healthcare Diagnostics Inc., USA) and DIAsource E2-RIA-CT 114	
(DIAsource ImmunoAssays S.A., Belgium) kits, respectively. Sensitivities and coefficients of variance 115	
were 0.01 ng/ml and 1 pg/ml, and 4.3% and 2.6%, respectively, for each assay.  116	
Bovine granulosa cells were cultured as described (21) and 24 h later were either left untreated or 117	
treated with forskolin (10 µM), bovine insulin (1 mg/ml) and FBS (1% v/v; all from Sigma-Aldrich) for 118	
up to 4 days to induce luteinization.   119	
 120	
RNA Extraction 121	
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Total RNA was extracted from snap-frozen tissues using the miRNeasy Mini kit (Qiagen) following 122	
homogenization with ceramic beads using FastPrep FP120 Cell disruptor (MP Biomedicals, UK).  RNA 123	
was analyzed using NanoDrop-1000 spectrophotometer (NanoDrop Technologies, Willmington, USA) 124	
and Agilent 2100 Bioanalyzer (Agilent Technologies Inc., UK).  RNA from cultured cells was isolated 125	
using TRIzol® Reagent (Life Technologies) and concentrations were determined using Quant-iT™ 126	
RiboGreen® RNA kit (Life Technologies). 127	
 128	
Microarray Analyses 129	
Bovine samples from 6 large (diameter, 12-17 mm), steroidogenically-active follicles (classified 130	
based on CYP19A1 and estradiol levels (8)) and 6 early corpora lutea were analyzed with the miRCURY 131	
LNA™ microRNA Array 6th generation (contained 1488 capture probes targeting all miRNAs for 132	
human, mouse or rat in miRBase 16.0) by Exiqon Services (Denmark), as described in detail (8).  133	
Differences in miRNA expression were determined using Student’s t-test with Benjamini and Hochberg 134	
False Discovery Rate (FDR) adjustment. Raw microarray data were deposited in NCBI’s GEO 135	
repository, GSE54692. 136	
 137	
RT-qPCR 138	
Individual miRNAs were analyzed using miScript II RT and miScript SYBR Green PCR kits, and 139	
miScript Primer Assays (Qiagen).  mRNA levels were quantified on the same cDNA using species-140	
specific primers (Table S1) and the SensiFASTTM SYBR Lo-ROX Kit (Bioline Ltd., UK). The 141	
MX3005P QPCR system (Stratagene, CA, USA) was used. Relative transcript abundance was obtained 142	
using MX3005P software by extrapolating Ct values from a standard curve prepared from a sample 143	
pool. Endogenous RnU6-2 was used for normalization of miRNA, and 18S or GAPDH were used to 144	
normalize mRNA data.   145	
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 146	
In Situ Hybridization  147	
In situ hybridization of frozen ovarian tissues was performed using a modified protocol (8) with 148	
double digoxigenin-labeled LNA probes (Exiqon) against bta-miR-132 (80nM), RnU6-2 (3nM) or a 149	
scrambled RNA sequence (40nM).  Independent analyses were performed on 3 different sections. 150	
 151	
Western blotting 152	
Total protein was obtained by adding buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 153	
0.004% bromophenol blue and 0.125 M Tris HCl, pH=6.8; Sigma-Aldrich) to cultured cells at 60ºC and 154	
then scraping off.  Samples were boiled for 5 min and electrophoresed in a 12% SDS-PAGE gel with 155	
Color-plus pre-stained marker (BioRAD, UK) in Mini Trans-Blot® Cell (BioRAD) at 150 volt for 90 156	
min. Gels were transferred to a 0.2 µM Nitrocellulose membrane (GE healthcare, UK) using Trans-157	
Blot® SD Semi-Dry Transfer Cell (BioRAD) at 15 volt for 60 min. After blocking, the blot was 158	
incubated with anti-FOXO1 (#2880; Cell Signaling, MA, USA; 1:500) or anti-β-Tubulin (#2146; Cell 159	
Signaling; 1:1000) overnight at 4°C, followed by washing and incubation with IRDye®680RD Donkey 160	
anti-rabbit IgG (926-68073; LI-COR Biosciences, UK; 1:10000) for 1h and visualization with LI-COR 161	
Odyssey infrared imaging scanner. Signal intensities were quantified using Image Studio Lite 5.0 (LI-162	
COR).  163	
 164	
Apoptosis assays 165	
Apoptosis was measured in triplicate in 96-well plates (2x10⁴	cells/well)	using Caspase-Glo 3/7 166	
assays (Promega Ltd, UK) and a Synergy BioTek micro-plate reader.  In addition, cells grown on 167	
coverslips were stained with Annexin-V-Fluos staining kit (Roche, UK) and visualized using a Leica 168	
DMLB fluorescence microscope. 169	
 170	
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Statistical analyses 171	
Data was analyzed using the GLM procedure by one-way or two-way ANOVA followed by Tukey’s 172	
pairwise comparison tests or, whenever only two experimental groups were compared, Student’s t-tests. 173	
In all cases, statistical significance was considered at P<0.05. 174	
 175	
Results 176	
The miR-183-96-182 and miR-212-132 clusters are highly upregulated during the follicular-177	
luteal transition.   To identify miRNAs potentially involved in the follicular-luteal transition in the 178	
monovular ovary we collected bovine large antral follicles and early cycle corpora lutea.  Expression 179	
profiles of selected genes were consistent with those naturally encompassing the follicle-luteal 180	
transition (Figure 1A).  Upon microarray analyses, a total of 545 probes yielded hybridization intensities 181	
above background across all samples, corresponding to 523 unique miRNAs including 191 sequences 182	
registered as bovine in miRBase 18.  Results of comparative analyses are shown in Figure 1B,C and 183	
Table S2.  184	
A total of 11 and 22 unique miRNAs were up- and down-regulated, respectively (≥2.5 fold; 185	
FDR<0.01), in corpora lutea relative to large antral follicles (Table 1).  The top 4 differentially 186	
expressed sequences corresponded to the homologues of human miR-183-5p, miR-96-5p, miR-182-5p 187	
and miR-132-3p, and were all upregulated in CL (Figure 1D,E).  These sequences derive from two 188	
different miRNA clusters, miR-183-96-182 and miR-212-132. Only one of the -3p homologues in the 189	
miR-183-96-182 cluster, miR-183, was also detected by microarray, and was slightly upregulated in 190	
the CL (1.15 fold; Table S2). In addition, the homologues of human miR-132-5p and miR-212-3p (none 191	
registered as a bovine sequence in miRBase 18), but not miR-212-5p, were also detected and were 192	
upregulated in CL (Table 1; Figure 1D,E).  Since bta-miR-96 and bta-miR-132 were the top upregulated 193	
miRNAs within each cluster (Figure 1D) and, based on Ct values, were also the most abundant in 194	
ovarian tissues, our subsequent analyses focused on these two miRNAs, for simplicity hereafter referred 195	
to as miR-96 and miR-132.  196	
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QPCR screening across bovine tissues revealed neither miR-96 nor miR-132 was restricted to the 197	
ovary (Figure 2A). Nevertheless, miR-132 was expressed at highest levels in CL, although in situ 198	
hybridization showed that within the CL this miRNA was broadly distributed, not restricted to any 199	
particular cell type (Figure 2B).   200	
Next, to ascertain whether the increase in miR-96 and miR-132 during luteinization involves 201	
granulosa-derived cells, the major source of luteal progesterone, we induced bovine granulosa cells to 202	
luteinize in culture (7) and showed that indeed this was associated with a distinct increase in the 203	
expression of miR-96, miR-132 and other miRNAs from the same genomic clusters (Figure 2C).   204	
FOXO1 is a putative target of miR-96 and miR-132 during the follicle-luteal transition.  To 205	
investigate the roles of miR-96 and miR-132 we first used TargetScan 7.1 and miRTarBase 6.0 to obtain 206	
lists of computationally predicted targets in human and bovine, and experimentally validated targets 207	
(available from humans and rodents), respectively.  To identify high-confidence targets we selected a 208	
subset of genes that 1) were predicted targets of both miRNAs, 2) contained conserved target sites and 209	
3) were known to be involved in luteal development (http://okdb.appliedbioinfo.net/), and we then 210	
determined their relative expression in ovarian tissues (Figure 2D).  In this way, the transcription factor, 211	
FOXO1, a critical regulator of cell survival and metabolism (23), was identified as high-confidence 212	
target based on its clearly decreased expression in CL relative to follicles.  The levels of other genes 213	
analyzed were only slightly lower (ACVR1A), not different (RASA1 and FOXO3) or higher (CDKN1A, 214	
MMP9 and HB-EGF) in CL than in follicles, indicating they may not naturally mediate the effects of 215	
those miRNAs during the follicle-luteal transition.  216	
miR-96 has an anti-apoptotic effect in hLGCs mediated by FOXO1.  To investigate the 217	
involvement of these miRNAs in the human ovary, we first determined changes in miRNA expression 218	
in hLGCs (corresponding to an early stage of luteinization) that had been treated with hCG to induce 219	
further differentiation in culture (24). Results showed that, as in bovine (Figure 2C), the two miRNAs 220	
are up-regulated in response to a luteinization stimulus in human cells (Figure 3A).   221	
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Next, we investigated whether, as suggested by the results of our miRNA target analyses, these two 222	
miRNAs may regulate luteal cell survival. We transfected hLGCs with anti-miRNAs (Figure 3B) and 223	
determined the effects on apoptotic responses to serum removal. We found that anti-miR-96 but not 224	
anti-miR-132 led to a significant mean increase (1.6-fold) in the Caspase 3/7 activation response to 225	
serum starvation (Figure 3C). Interestingly, similar Caspase 3/7 responses were obtained even in non-226	
stressed cells maintained in serum; in addition, under those conditions, simultaneous inhibition of both 227	
miRNAs produced a Caspase 3/7 response similar to that induced by inhibition of miR-96 only (Figure 228	
3D). The pro-apoptotic effect of miR-96 inhibition was confirmed by V-Annexin staining (Figure 3E).   229	
We then determined whether the effects of miR-96 could be mediated by its putative target, FOXO1. 230	
Indeed, inhibition of miR-96 induced a robust mean increase (1.8-fold) in FOXO1 protein one day after 231	
transfection (Figure 3F), with a slightly smaller (1.7-fold) although significant increase induced also by 232	
miR-132 inhibition; again, simultaneous inhibition of the two miRNAs did not have a synergistic effect 233	
on FOXO1 levels. To confirm a causal involvement of FOXO1 in the observed apoptotic response to 234	
anti-miR-96, we transfected cells simultaneously with anti-miR-96 and FOXO1 siRNA. We showed 235	
that this effectively prevented both an increase in FOXO1 protein (Figure 3G) and the activation of 236	
Caspase 3/7 (Figure 3H) in response to anti-miR-96 thus indicating that miR-96 promotes hLGC 237	
survival by targeting FOXO1. 238	
miR-96 promotes progesterone production by hLGCs through targeting FOXO1. Given the 239	
reported involvement of miRNAs in steroidogenesis (10,11), we investigated the short-term effects of 240	
miR-96 and miR-132 on progesterone and estradiol production by analyzing spent culture media of 241	
hLGCs transfected with anti-miR-96 and/or anti-miR-132 (Figure 4A). All treatments resulted in a 242	
decrease in mean progesterone levels at 24h, however, this was significant only in response to anti-243	
miR-96, alone or in combination with anti-miR-132 (>1.6-fold, P<0.01). Moreover, the effects of anti-244	
miRs on progesterone were transient as differences were no longer detected 48h after transfection 245	
(P>0.1; not shown).  In contrast, significant changes in estradiol levels were not detected (P>0.1) in 246	
response to transfection with anti-miRNAs. 247	
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We then determined whether the observed stimulatory effects of miR-96 on progesterone may 248	
involve repression of FOXO1. This was indeed the case, as transfection with FOXO1 siRNA prevented 249	
the temporary reduction in progesterone levels by anti-miR-96 (Figure 4B), indicating that, in hLGCs, 250	
an inhibitory effect of FOXO1 on progesterone synthesis is relieved by an increase in miR-96 upon 251	
luteinization.   252	
To investigate the mechanisms behind the observed effects of miR-96 and FOXO1 on steroid levels, 253	
we quantified the expression of several genes involved along the cholesterol and steroid synthesis 254	
pathways (Figure 4C), the transcript levels of  which were previously shown to be regulated by FOXO1 255	
in rodent granulosa cells (25). We did not detect significant differences in the levels of any of the 256	
transcripts analyzed in response to inhibition of miR-96 in the absence or presence of FOXO siRNA, 257	
indicating that distinct molecular mechanisms, which could possibly include changes in protein levels 258	
and/or activity of steroidogenic gene products, may account for the effects of FOXO1 in steroid 259	
production in hLGCs.    260	
The anti-apoptotic effects of miR-96 are conserved in bovine luteal cells. Finally, to investigate 261	
the functional conservation of miR-96 during the follicle-luteal transition in other species we 262	
established whether the observed effects of this miRNA in human ovarian cells also occurred in bovine. 263	
We collected cells from bovine corpora lutea and cultured them in the presence or absence of anti-miR-264	
96. Consistent with data in human (Fig 3C), inhibition of miR-96 (Fig 5A) led to an increase in Caspase 265	
3/9 activity in response to serum deprivation (Fig 5B), together with an increase in FOXO1 protein 266	
levels (Fig 5C). In contrast, progesterone production by bovine cells was not affected by miR-96 267	
inhibition (not shown).  268	
 269	
Discussion 270	
Little is known about the molecular regulation of the follicle-luteal transition in humans, to a large 271	
extent due to the limited availability of healthy ovarian tissues for study.  In this regard, monovular 272	
species such as cattle can provide extremely valuable insight, particularly when compared to common 273	
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rodent models with much more distinct ovarian physiology (26,27).  In this study, we demonstrate the 274	
value of this comparative approach by identifying, using the bovine model, a novel miRNA-mediated 275	
mechanism involved in functional regulation of the human corpus luteum. 276	
The finding of an increase in the expression of the miR-183-96-182 and miR-212-132 clusters, as 277	
well as miR-21, during luteinization is consistent with results of previous studies in other species, 278	
including bovine (7,13,28-31), overall suggesting conserved roles of these miRNAs during the follicle-279	
luteal transition.  However, although an effect of miR-21 in promoting cell survival during ovulation 280	
has already been demonstrated, at least in mice (16), the precise roles of the miR-183-96-182 and miR-281	
212-132 clusters, the most upregulated miRNAs during the follicle-luteal transition, had so far not been 282	
defined during that transition.   283	
Studies in rodents showed FOXO1 to regulate different granulosa cell pathways involved in 284	
proliferation, survival and differentiation (25,32-34), and ovarian FOXO1 expression to rapidly 285	
terminate in response to the ovulatory gonadotropin surge (35). Moreover, FOXO1 was experimentally 286	
validated as miR-96 target in human (36,37) and cattle (29).  Indeed, the latter was the only study so far 287	
to show targeting of FOXO1 by the miR-183-96-182 cluster specifically in granulosa cells, which 288	
reportedly enhanced cell proliferation. In contrast, we found no evidence of an effect of miR-96 or miR-289	
132 on proliferation of luteal cells (not shown). Cell cycle arrest (rather than proliferation) associated 290	
with activation of survival pathways is a hallmark of luteinization(1), consistent with the anti-apoptotic 291	
effects of miR-96 in both human and bovine cells in our study.  Taken together, our results and those 292	
of (29) indicate that the effects of the miR-183-96-182 cluster may depend on the stage of follicle/luteal 293	
development. Most importantly, we identify miR-96 as a novel mediator of a key effect of the ovulatory 294	
LH surge, promotion of luteal cell survival, through targeting of FOXO1. 295	
Granulosa-derived cells are the main source of luteal progesterone. The observed decrease, albeit 296	
short-lasting, in progesterone production by hLGCs in response to anti-miR-96 indicates a stimulatory 297	
effect of miR-96 on this crucial function.  In contrast, a previous study reported an inhibitory effect of 298	
miR-96 on progesterone production by human non-differentiated granulosa cells, suggesting the effects 299	
of this miRNA may be developmental stage-specific(12)  Moreover, we show the inhibitory effects of 300	
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miR-96 to be mediated through downregulation of FOXO1. Studies in rodent granulosa cells (25) 301	
provided evidence that FOXO1 may target several genes along the cholesterol/steroid synthesis 302	
pathway (including hmgcs1, nr5a1, star, cyp11a1, cyp19a1 and cyp271a1) acting to prevent a 303	
premature increase in follicular steroid production before luteinization. Our results implicate miR-96 in 304	
modulating the effect of FOXO1 on steroidogenesis in humans, however, since we did not detect 305	
significant changes in the transcripts for the above cholesterol/steroid-producing genes, further 306	
investigation of the downstream mechanisms involved is warranted. In contrast to hLGCs, an effect of 307	
miR-96 inhibition on progesterone production by bovine luteal cells was not observed. Since, compared 308	
to human cells, bovine cells were collected from relatively mature corpora lutea, our finding suggests 309	
the stimulatory effects of miR-96 may occur only during the initial stages of luteinization; alternatively, 310	
these results may be explained by the heterogeneous nature of the bovine luteal cell preparations used 311	
in our study (containing not only granulosa-derived but also other luteal cell types) or may reflect 312	
intrinsic differences in regulation of luteal progesterone production between humans and cattle, e.g., 313	
the distinct dependence of human granulosa lutein cells on LH (1).         314	
Because of its relative high abundance in luteal cells allowing robust downregulation using LNAs, 315	
we focused our analyses on miR-96. However, it should be noted that all miR-183-96-182 cluster 316	
miRNAs have similar seed sequences, and there is evidence they coordinately regulate some target 317	
genes (29,36,38); thus, all 3 miRNAs are expected to contribute to luteal regulation in vivo.  Further 318	
complexity in predicting physiological effects of these miRNAs is provided by the fact that they 319	
presumably act in coordination with other miRNAs, for example, the anti-apoptotic miR-21 (16), thus 320	
ensuring robust follicular differentiation. 321	
Finally, in contrast to anti-miR-96, miR-132 inhibition had in our study only small, non-significant 322	
effects on hLGCs, particularly in relation to cell survival, and in addition did not enhance the effects of 323	
miR-96 alone. Yet, albeit to a slightly lower extent than anti-miR-96, miR-132 inhibition did induce an 324	
increase in FOXO1 protein, in agreement with this being an experimentally validated target of miR-132 325	
(39,40). Although we do not have an explanation for the relatively minor cell responses to miR-132 326	
compared to miR-96 in the face of similar inhibitory effects on FOXO1, this may reflect differences in 327	
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specific effector mechanisms elicited by the two miRNAs, a possibility that should be investigated in 328	
the future.  Moreover, in line with our results, inhibition of miR-132 and miR-212 in a previous study 329	
had no obvious effects on steroid production by mouse granulosa cells, overall suggesting the miR-212-330	
132 cluster may instead be involved in other aspects of the follicle-luteal transition. 331	
In summary, using a cross-species approach we identified miR-96 as a novel regulator of the follicle-332	
luteal transition, through FOXO1-mediated promotion of luteal cell survival and progesterone 333	
production. Reported wider roles for FOXO1 in the ovary suggest that miR-96, and indeed the miR-334	
183-96-182 cluster, likely has broader effects during the follicle-luteal transition. Such effects may be 335	
important not only in ensuring a normal luteal phase but also in regulating luteal rescue and the 336	
establishment of pregnancy, a potential key link for investigation in future studies.  337	
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Figure legends 447	
 448	
Figure 1. A) Relative mean (± SE) transcript levels of LHCGR, CYP19A1 and HSD3B1 in bovine 449	
ovulatory size follicle (12-17 mm; n = 6) and early corpora lutea (n = 6) samples used for microarray 450	
analyses.  B, C) Heat map representation (B) and Principal Component Analyses Plot (C) of top 50 451	
miRNA probes with highest standard deviation in bovine ovulatory size follicles and early corpora 452	
lutea. Each row in the heat map represents a miRNA and each column represents a sample. The color 453	
scale illustrates the relative expression level of miRNAs. Red color represents an expression level below 454	
the reference channel and green color represents expression higher than the reference. For PCA plot 455	
analysis, the normalized log ratio values were used. The features were shifted to be zero centered, (i.e. 456	
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the mean value across samples was shifted to 0) and scaled to have unit variance (i.e. the variance across 457	
samples was scaled to 1 before the analysis). Raw microarray data were deposited in the NCBI’s GEO 458	
repository, GSE54692).  D) Levels (mean ± SE), obtained by qPCR, of top transcripts identified by 459	
microarray as up- or down-regulated in early CL relative to ovulatory-size follicles. E) Comparative 460	
mean fold changes in miRNA expression between bovine early CL and ovulatory-size follicles obtained 461	
by microarray and qPCR.  In all panels, differences between two means, determined by t-test, are shown 462	
by * (P<0.05) and ** (P<0.01). 463	
Figure 2. A) Relative abundance of miR-96 and miR-132 across several bovine tissues. For each 464	
tissue, RNA samples from 3 to 5 animals were pooled and analyzed by qPCR. CL– corpus luteum, 465	
PBMC – polymorphonuclear cells.  B) Localization of miR-132 within the bovine CL by in situ 466	
hybridization. Frozen ovarian sections were hybridized with DIG-labelled LNA probe against 467	
scrambled RNA (negative control, left panel), bta-miR-132 (middle panel) and RnU6 snRNA (positive 468	
control, right panel), scale = 100 um, 20x. C) Changes in relative miRNA levels (mean ± SE) during in 469	
vitro luteinization of bovine granulosa cells. Granulosa cells were cultured for 4 days with or without 470	
media containing forskolin, insulin and FBS to induce luteinization (n = 5 experiments). Data are shown 471	
relative to expression values on Day 0. Group means with different letters (a,b,c) are different (P<0.05). 472	
D) Relative mean (± SE) transcript levels, quantified by qPCR, of predicted common targets of miR-96 473	
and miR-132 in bovine ovulatory size follicles (9-17 mm; n = 6) and early corpora lutea (n = 6).  For 474	
each gene, mean differences (P<0.05) are shown by *.  475	
Figure 3.  A) Relative levels of miR-96 and miR-132 in human luteinized granulosa cells treated 476	
with hCG (100 ng/ml) for 4 days or left untreated.  B) Relative levels of miRNAs following transfection 477	
of human luteinized granulosa cells with the indicated oligonucleotides. C, D) Caspase 3/7 activity in 478	
transfected human luteinized granulosa cells with (C) or without (D) previous serum removal for 12h. 479	
E) Representative pictures (scale = 100 um, 20x) showing Annexin V staining (green; PI staining is 480	
shown in red) of human luteinized granulosa cells 24h after transfection with the indicated 481	
oligonucleotides. F) Relative levels of FOXO1 protein after transfection of human luteinized granulosa 482	
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cells with the indicated oligonucleotides. A representative western blot is shown.  G) Representative 483	
FOXO1 and B-tubulin western blots of human luteinized granulosa cells transfected with the indicated 484	
oligonucleotides for one day. H) Caspase 3/7 activity following transfection of human luteinized 485	
granulosa cells with the indicated oligonucleotides. In all experiments, oligonucleotides were 486	
transfected at the following concentrations: scramble oligonucleotide (50 or 100 nM, negative control), 487	
anti-miR-96 (50 nM), anti-miRNA-132 (50 nM), anti-miR-96 + anti-miR-132 (25 nM and 25 nM) and 488	
FOXO siRNA (100 nM). Values shown for each time-point were in all cases normalized to the 489	
corresponding value at the time of transfection (Day 0 or Hour 0).  Data are shown as mean ± SE (n=3 490	
- 6 experiments). Significant differences (P<0.05) between two means are shown by a star (A). For 491	
comparisons involving more than two means, different letters (a,b,c) are used to indicate significance 492	
(P<0.05). In F, mean FOXO1 values were compared across groups within each Day.  493	
Figure 4. A, B) Levels of progesterone (A, B) and estradiol (A) in spent culture media one day after 494	
transfection of human luteinized granulosa cells with the indicated oligonucleotides (n = 6 experiments). 495	
C) Transcript levels of different genes involved in cholesterol and steroid production, quantified by 496	
qPCR in human luteinized granulosa cell samples collected one day after transfection with the indicated 497	
oligonucleotides (n = 3 experiments).   Mean (± SE) values are shown and were normalized to values 498	
on the day of transfection (Day 0). Group means with different letters (a,b,c) are different (P<0.05).  499	
Figure 5. A,B,C) Relative levels (mean ± SE) of miR-96 (A), Caspase 3/7 activity (B) and FOXO1 500	
protein (C) following transfection of bovine luteal cells with scramble oligonucleotide (50 nM, negative 501	
control) or anti-miR-96 (50 nM) at the indicated times (n=3 experiments).  A representative western 502	
blot is shown in C.  Values shown for each time-point were in all cases normalized to the corresponding 503	
value at the time of transfection (Day 0 or Hour 0).  Significant differences (P<0.05) between means 504	
are shown by different letters (a,b,c).  In C, mean FOXO1 values were compared between groups within 505	
each Day, and differences are indicated by * (P<0.05).  506	
 507	
Table 1. miRNAs differentially expressed (≥ 2.5 fold) between early corpora 
lutea and pre-ovulatory size follicles in cow. 
miRNA   Fold-change 
 
Upregulated in corpus luteum 
hsa-miR-182-5p/bta-miR-182 8.80 
hsa-miR-96-5p/bta-miR-96 7.55 
hsa-miR-132-3p/bta-miR-132 7.11 
hsa-miR-183-5p/bta-miR-183 5.42 
hsa-miR-223-3p/bta-miR-223 4.79 
hsa-miR-378a-3p/hsa-miR-378c/hsa-miR-378d/bta-miR-378 3.35 
hsa-miR-3182 3.30 
hsa-miR-132-5p 3.20 
hsa-miR-708-5p/bta-miR-708 3.11 
hsa-miR-212-3p 2.71 
bta-miR-21 2.67 
  
Downregulated in corpus luteum 
hsa-miR-1290 5.24 
hsa-miR-1246 4.42 
hsa-miR-143-3p/bta-miR-143 3.93 
hsa-miR-642b-3p 3.85 
hsa-miR-4328 3.63 
hsa-miR-145-5p/bta-miR-145 3.40 
hsa-miR-125b-5p/bta-miR-125b 3.12 
hsa-miR-195-5p/bta-miR-195 3.03 
hsa-miR-149-3p 2.98 
hsa-miR-424-5p 2.96 
hsa-miR-574-5p 2.92 
hsa-miR-10b-5p/bta-miR-10b 2.83 
bta-miR-26a 2.76 
hsa-miR-99a-5p/bta-miR-99a 2.73 
hsa-miR-491-3p 2.67 
bta-let-7b 2.65 
hsa-miR-100-5p/bta-miR-100 2.60 
hsa-miR-130a-3p/bta-miR-130a 2.59 
hsa-miR-101-3p/bta-miR-101 2.52 
hsa-miR-125a-5p/bta-miR-125a 2.52 
hsa-miR-32-3p 2.51 
hsa-miR-30c-5p/bta-miR-30c 2.51 
 
miRNA nomenclature according to miRBase 21 
n = 6 animals per tissue type 
P-value (Benjamini and Hochberg adjusted) <0.01 in all cases 
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